BSECompany Update6d ago · 24 Jul 2026, 12:27 pm
Pursuant to Regulation 30 of the SEBI Listing Regulations, we hereby inform you that the Company has scheduled an Investor Result Conference Call on Wednesday, 12th August, 2026 at 10:00 ....
Nephrocare Health Services Ltd · 544647
✦ AI SummaryResults
Nephrocare Health Services Ltd has scheduled an Investor Result Conference Call on August 12, 2026, to discuss its Q1FY27 financial results.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Nephrocare Health Services Ltd - 544647 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
7a371968-9f83-4c5d-a517-7b9d136903b6.pdf
View document text
Ref: NEPHROPLUS/SE/066
July 24, 2026
To To
BSE Limited National Stock Exchange of India Limited
P.J. Towers, Dalal Street, 5th Floor, Exchange Plaza, Bandra (E),
Mumbai – 400 001 Mumbai – 400 051
Scrip Code: 544647 Scrip Symbol: NEPHROPLUS
Through: BSE Listing Centre Through: NEAPS
Sub: Intimation of schedule of Q1FY27 Earnings Call
Ref: Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”)
Dear Sir/Madam,
Pursuant to Regulation 30 read with Schedule III of the SEBI Listing Regulations, as amended
from time to time, we would like to inform you that the officials of the Company will be
attending a Results Conference Call to discuss on Unaudited standalone and consolidated
financial results of the Company for the quarter ended June 30, 2026 as per the details below:
Day, Date & Time Type of Event
Wednesday, August 12, 2026 at 10:00 A.M IST Q1FY27 Earnings Call
Discussions will be based on publicly available information. No unpublished price sensitive
information (UPSI) is intended to be discussed during the interactions.
The above disclosure is available on the website of the Company www.nephroplus.com
A copy of the invitation is attached for your information.
Yours sincerely,
For Nephrocare Health Services Limited
(Formerly Nephrocare Health Services Private Limited)
Kishore Kathri
Company Secretary & Head Legal
ICSI M. No. F9895
Encl: a/a
NephroPlus
Earnings Conference Call
Wednesday, 12th Aug 2026
10:00 am (IST)
IIFL is pleased to invite you to join a conference call with the management of NephroPlus (NEPHROPL IN) to discuss the
company’s business strategy and outlook post the declaration of its Q1FY27 financial results.
Mr. Vikram Vuppala – Chairman & Managing Director
Mr. Kamal Shah – Co-Founder
Management participants
Mr. Rohit Singh – Group CEO
Mr. Prashant Goenka – Group Chief Financial Officer
12th Aug 2026 (Wednesday) – 10:00 am IST
Date / Time
(HK/Singapore – 12:30 pm, UK – 5:30 am, USA – 12:30 am ET)
Conference dial-in numbers
Pre-registration link Diamond Pass Registration
India
Primary Number +91 22 6280 1259 / +91 22 7115 8160
International Toll-free number
USA 1-866 746 2133
UK 0-808 101 1573
Singapore 800-101 2045
Hong Kong 800-964 448
For further information, please contact:
Naman Bagrecha | Tel: +91 22 4646 4718 | Email: naman.bagrecha@iiflcap.com
Rahul Jeewani | Tel: +91 22 4646 4673 | Email: rahul.jeewani@iiflcap.com
Aman Goyal | Tel: +91 22 4646 4705 | Email: aman.goyal@iiflcap.com
Vighnesh Indure | Tel: +91 22 4646 4661 | Email: vighnesh.indure@iiflcap.com
IIFL Capital Services Limited - 24th floor, One Lodha Place, Senapati Bapat Marg, Lower Parel (W), Mumbai 400 013, Tel: (91-22) 4646 4600, Fax: (91-22) 4646 4700